| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | President And CEO
1 company
Watanabe Todd is a See Remarks at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $19.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sell | 1,750 | $30.55 | $53,462.50 | -0.3% | -14.4% | -46.3% | |
| Mar 2, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sell | 2,107 | $35.19 | $74,136.06 | -0.4% | -21.7% | -47.8% | |
| Feb 5, 2021 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 10,000 | $34.29 | $342,915.67 | -0.9% | -11.8% | -60.0% | |
| Sep 29, 2020 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 3,000 | $30.00 | $90,000.00 | -0.5% | - | - | |
| Sep 29, 2020 | ARQT Arcutis Biotherapeutics, Inc. | President And CEO | Sale+OE | 3,000 | $30.00 | $90,000.00 | -0.5% | - | - |